Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Central Nervous System Neoplasms × Lenalidomide × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 36 Lymphoma, Follicular 13 Lymphoma, Large B-Cell, Diffuse 11 Lymphoma 7 Lymphoma, Non-Hodgkin 6 Recurrence 5 Lymphoma, B-Cell, Marginal Zone 5 Lymphoma, Mantle-Cell 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Neoplasms, Plasma Cell 3 Neoplasms 3 Smoldering Multiple Myeloma 2 Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Chronic 2 Hodgkin Disease 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Paraproteinemias 1 Neuroblastoma 1 Neoplasm, Residual 1 Lymphoproliferative Disorders 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, B-Cell 1 Leukemia, Hairy Cell 1 Intraocular Lymphoma 1 Immunoproliferative Disorders 1 HTLV-I Infections 1 GATA2 Deficiency 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Magnetic Resonance Spectroscopy 4 Biopsy 3 X-Rays 2 Specimen Handling 2 Phantoms, Imaging 2 Nuclear Medicine Department, Hospital 2 regorafenib 1 pembrolizumab 1 erdafitinib 1 ensartinib 1 cabozantinib 1 alectinib 1 aflibercept 1 Surveys and Questionnaires 1 Radiotherapy 1 Radiation 1 Paclitaxel 1 ONC206 1 Nivolumab 1 NEO212 1 Lomustine 1 Ipilimumab 1 IFL protocol 1 Gadolinium 1 Ferrosoferric Oxide 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡